Cseh et al. "Alternative Cleavage of the Cachectin/TNF Propeptide Results in a Larger Inactive Form of Secreted Protein" JBL 264 16256-16260 1989. |
Tracey et al., "Ant-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia," Nature, 330:662-664 (Dec. 17, 1987). |
Decker et al., "Cell-Associated Tumour Necrosis Factor (TNF) as a Killing Mechanism of Activated Cytotoxic Macrophages," J. Immunol., 138:957-962 (Feb. 1, 1987). |
Kriegler et al., "A Novel Form of TNF/Cachetin Is a Cell Surface Cytotoxic Transmembrane Protein: Ramifications for the Complex Physiology of TNF," Cell, 53:45-53 (Apr. 8, 1988). |
Folks et al., "Tumour necrosis factor .alpha. induces expression of human immunodeficiency virus in a chronically infected T-cell clone," PNAS (USA), 86:2365-2368 (Apr. 1989). |
Elliot, et al., "Treatment of Rheumatoid Arthritis With Chimeric Antibodies to tumour Necrosis Factor .alpha.," Arthritis & Rheumatism, 36:1681-1690 (Dec. 1993). |
Seckinger et al., "A Human Inhibitor of Tumour Necrosis Factor .alpha.," J. Exp. Med.. 167:1511-1516 (1988). |
Seckinger et al., "Purification and Biologic Characterization of a Specific Tumour Necrosis Factor .alpha. Inhibitor," J. Biol. Chem., 264:11966-11973 (1989). |
Dinarello et al., "Multiple biological Activities of Human Recombinant Interleukin-1," J. Clin. Invest. 77:1734-1739 (1986). |
Arend et al., "Effects of Immune Compleses on Production by Human Monocytes of Interleukin-1 or an Interleukin-1 Inhibitor," J. Immunol., 134:3868-3975 (1985). |
Seckinger et al., "A Urine Inhibitor of Interleukin-1 Activity that Blocks Ligand Binding," J. Immunol., 139:1546-1549 (1987). |
Hannum et al., "Interleukin-1 Receptor Antagonist Activity of a Human Interleukin-1 Inhibitor," Nature, 343:336-340 (1990). |
Eisenberg et al., "Primary Structure and Expression from Complementary DNA of a Human Interleukin-1 Receptor Antagonist," Nature, 343:341-346 (1990). |
Kostura et al., "Identification of a monocyte specifc pre-interleukin 1.beta. convertase activity," PNAS (USA), 86:5227-5231 (Jul. 1989). |
Scott et al., "Immunogenicity of Biotinylated Hapten-Avidin Complexes," Molecular Immunology, 21:1055-1060 (1984). |
Tsuchiya et al., "Establishment and Characterization of a Human Acute Monocytic Leukemia Cell Line (THP-1)," Int. J. Cancer, 26:171-176 (1980). |
Krakauer & Oppenheim, "Interleukin 1 Production by a Human Acute Monocytic Leukemia Cell Line," Cell. Immunol., 80:223-229 (1983). |
Silman & Katchalski, "Water-Insoluable Derivatives of Enzymes Antigens and Antibodies," Ann. Rev. Biochem., 35:873-908 (1966). |
Shadle et al., "Human Macrophage Colony-Stimulating Factor Heterogeneity Results From Alternative mRNA Splicing, Differential Glycosylation, and Proteolytic processing," J. Cell. Biochem., 40:91-107 (1989). |
Cseh et al., "Alternative Cleaveage of the Cachectin/TNF Propetide Results in a Larger, Inactive Form of Secreted Protein," J. Biol. Chem., 264:16256-16260 (1989). |
Merrifield, "Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide," J. Amer. Chem. Soc., 85:2149-2154 (Jul. 20, 1963). |
Webb, "Arthritis Wonder Cure Wins Cautious Welcome," New Scientist, p. 16, (Feb. 12, 1994). |
Elliott et al., "Treatment of Rheumatoid Arthritis with Chimeric Monoclonal Antibodies to Tumour Necrosis Factor .alpha.," Arthritis & Rheumatism, 36:1681-1690 (Dec. 1993). |
Merrifield, "Solid Phase Synthesis," Science 232:341-347 (Apr. 18. 1986). |
Beutler et al., "Passive Immunization Against Cachectin/Tumour Necrosis Factor Protects Mice from Lethal Effect of Endotoxin," Science, 229:869-871 (Aug. 30 ,1985). |
Ohlsson et al., "Interleukin-1 receptor antagonist reduces mortality from endotoxin shock," Nature, 348:550-552 (Dec. 6, 1990). |
Pickup et al., "Suppression of Inflammatory Responses to Viral Infection: Viral Inhibition of the IL-1.beta. Convertase," J. Cell. Biochem., vol. 16, Supp. B, p. 285, Abstr. J217 (1992). |
Sleath et l., "Substrate Specificity of the Protease That Processes Human Interleukin-1.beta.," J. Biol. Chem., 265:14526-14528 (Aug. 25, 1990). |
Kobayashi et al., "Human Pre-interleukin 1.alpha.and .beta.: Structural Features Revealed by Limited Proteolysis," Chem. Pharm. Bull., 39:1513-1517 (Jun., 1991). |